Civil society organizations come forth with a Joint Statement in advance of the 39th meeting of the Global Fund Board

08/05

With a joint statement addressed to the Global Fund, more than 40 international, regional and national organizations have voiced their…

Ageing with HIV: New challenges and unmet needs of people aged 18 – 50 years living and ageing with HIV/AIDS (3-6 May 2018, Kiev)

02/05

The closing meeting from the third phase of the Ageing with HIV project is kicking off tomorrow in Kiev and…

Webinar: Results of the METRODORA research on the involvement of women in HIV clinical trials

26/04

EATG will host a webinar on the Results of the METRODORA research on the involvement of women in HIV clinical…

New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

18/05

While EMA review is ongoing, dolutegravir should not be used in women seeking to become pregnant The European Medicines Agency…

NIH statement on HIV Vaccine Awareness Day – May 18, 2018

18/05

Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) Maureen M. Goodenow,…

5 developments in HIV vaccine research over the past year

18/05

In 1984 — the same year that HIV was recognized as the cause of AIDS — then HHS Secretary Margaret Heckler announced…

Civil society organizations come forth with a Joint Statement in advance of the 39th meeting of the Global Fund Board

08/05

With a joint statement addressed to the Global Fund, more than 40 international, regional and national organizations have voiced their…

Ageing with HIV: New challenges and unmet needs of people aged 18 – 50 years living and ageing with HIV/AIDS (3-6 May 2018, Kiev)

02/05

The closing meeting from the third phase of the Ageing with HIV project is kicking off tomorrow in Kiev and…

Webinar: Results of the METRODORA research on the involvement of women in HIV clinical trials

26/04

EATG will host a webinar on the Results of the METRODORA research on the involvement of women in HIV clinical…

New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

18/05

While EMA review is ongoing, dolutegravir should not be used in women seeking to become pregnant The European Medicines Agency…

NIH statement on HIV Vaccine Awareness Day – May 18, 2018

18/05

Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) Maureen M. Goodenow,…

5 developments in HIV vaccine research over the past year

18/05

In 1984 — the same year that HIV was recognized as the cause of AIDS — then HHS Secretary Margaret Heckler announced…